Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) Shares Shorted: Short Interest Down 45.0% in October

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX – Get Free Report) was the target of a significant decline in short interest in October. As of October 30th, there was short interest totaling 2,770 shares, a decline of 45.0% from the October 15th total of 5,039 shares. Based on an average trading volume of 15,335 shares, the short-interest ratio is currently 0.2 days. Approximately 5.0% of the company’s stock are short sold.

Insider Buying and Selling

In related news, CEO Jodie Pope Morrison sold 3,221 shares of the business’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $8.32, for a total transaction of $26,798.72. Following the sale, the chief executive officer owned 340,038 shares of the company’s stock, valued at $2,829,116.16. The trade was a 0.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Shelia M. Violette sold 2,798 shares of the company’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $16.56, for a total transaction of $46,334.88. Following the completion of the sale, the insider owned 127,771 shares in the company, valued at approximately $2,115,887.76. This trade represents a 2.14% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 22,054 shares of company stock valued at $320,397 over the last quarter.

Leverage Shares 2X Long FIX Daily ETF Stock Performance

Leverage Shares 2X Long FIX Daily ETF stock opened at $5.09 on Monday. Leverage Shares 2X Long FIX Daily ETF has a twelve month low of $3.83 and a twelve month high of $15.92. The stock has a 50 day moving average of $10.29.

About Leverage Shares 2X Long FIX Daily ETF

(Get Free Report)

Homology Medicines, Inc. was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders. Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases. Homology also explored the use of its platform for gene editing and other genetic medicine applications.

Featured Stories

Receive News & Ratings for Leverage Shares 2X Long FIX Daily ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leverage Shares 2X Long FIX Daily ETF and related companies with MarketBeat.com's FREE daily email newsletter.